Search results for "DEFICIENCY"

showing 10 items of 1071 documents

Factor VII deficiency: evidence that in minor surgery one-day replacement therapy is sufficient

2011

Inherited FACTOR VII DEFICIENCY MINOR SURGERY INVASIVE PROCEDURESSettore MED/15 - Malattie Del Sangue
researchProduct

Oral Communication

2012

Inherited factor VII (FVII) deficiency is the most common of the rare autosomal recessive bleeding disorders (RBD), with an estimated prevalence of 1 per 300,000 in European countries.1,2 It is likely that the prevalence is higher in those countries where consanguineous marriages are frequent.We here report STER study results on 112 evaluable enrolled cases

Inherited Factor VII deficiency prophylaxisspontaneous bleeding episodesSettore MED/15 - Malattie Del Sangue
researchProduct

Changes in CD4+ cells’ miRNA expression following exposure to HIV-1

2010

Background: Micro RNAs (miRNAs) inhibit HIV-1 expression by either modulating host innate immunity or by directly interfering with viral mRNAs. Here, we investigated the miRNA profile that discriminates different classes of HIV-1-infected patients from multiple-exposed uninfected individuals. Methods: The expression levels of 377 miRNAs were selectively analysed in CD4+ cells isolated from whole blood of HIV-1 elite LTNP (eLTNP), naive, and multiply exposed uninfected individuals (MEUs). MiRNA extraction was performed by the mir Vana™ miRNA Isolation Kit (Ambion), and their expression was subsequently examined by real-time PCR-based arrays. The expression of miRNAs was also determined in pr…

Innate immune systembiologybusiness.industryHuman immunodeficiency virus (HIV)Public Health Environmental and Occupational Healthmedicine.disease_causemedicine.diseaseIn vitroImmune systemInfectious DiseasesAcquired immunodeficiency syndrome (AIDS)microRNAImmunologymedicinebiology.proteinOral PresentationbusinessDroshaDicerJournal of the International AIDS Society
researchProduct

Hemin-coupled iron(III)-hydroxide nanoparticles show increased uptake in Caco-2 cells

2011

Abstract Objectives The absorption of commonly used ferrous iron salts from intestinal segments at neutral to slightly alkaline pH is low, mainly because soluble ferrous iron is easily oxidized to poorly soluble ferric iron and ferrous iron but not ferric iron is carried by the divalent metal transporter DMT-1. Moreover, ferrous iron frequently causes gastrointestinal side effects. In iron(III)-hydroxide nanoparticles hundreds of ferric iron atoms are safely packed in nanoscaled cores surrounded by a solubilising carbohydrate shell, yet bioavailability from such particles is insufficient when compared with ferrous salts. To increase their intestinal uptake iron(III)-hydroxide nanoparticles …

Inorganic chemistryTetrazolium SaltsPharmaceutical ScienceNanoparticleFerrozineIron Chelating AgentsFerric CompoundsFerrouschemistry.chemical_compoundMicroscopy Electron TransmissionSpectroscopy Fourier Transform InfraredmedicineHumansScattering RadiationParticle SizeColoring AgentsHemePharmacologyChemistryIron Chelating AgentsIron deficiencymedicine.diseaseCulture MediaThiazolesHeminNanoparticlesHydroxideColorimetrySpectrophotometry UltravioletProtoporphyrinCaco-2 CellsHeminJournal of Pharmacy and Pharmacology
researchProduct

Isolated childhood growth hormone deficiency: a 30-year experience on final height and a new prediction model

2022

Purpose We aimed to evaluate the near-final height (nFHt) in a large cohort of pediatricpatients with growth hormone deficiency (GHD) and to elaborate a new predictive method of nFHt. Methods We recruited GHD patients diagnosed between 1987 and 2014 and followed-up until nFHt. To predict the values of nFHt, each predictor was run in a univariable spline. Results We enrolled 1051 patients. Pre-treatment height was -2.43 SDS, lower than parental height (THt) (-1.09 SDS, p < 0.001). The dose of recombinant human GH (rhGH) was 0.21mg/kg/week at start of treatment. nFHt was -1.08 SDS (height gain 1.27 SDS), higher than pre-treatment height (p < 0.001) and comparable to THt. 1.6% of the pat…

Insulin-like growth factor 1Human Growth HormoneEndocrinology Diabetes and MetabolismPubertyFinal height; Growth; Growth hormone deficiency; Growth hormone retesting; Insulin-like growth factor 1; LMG method; PredictionDwarfismGrowthBody HeightCohort StudiesEndocrinologySettore MED/38 - Pediatria Generale E SpecialisticaGrowth hormone retestingPituitaryFinal heightGrowth HormoneFinal height; Growth; Growth hormone deficiency; Growth hormone retesting; Insulin-like growth factor 1; LMG method; Prediction; Body Height; Child; Cohort Studies; Growth Hormone; Humans; Puberty; Dwarfism Pituitary; Human Growth HormoneHumansGrowth hormone deficiencyLMG methodDwarfism PituitaryPredictionChildFinal height Growth Growth hormone deficiency Growth hormone retesting Insulin-like growth factor 1 LMG method Prediction
researchProduct

Cholesterol Dependence of Collagen and Echovirus 1 Trafficking along the Novel α2β1 Integrin Internalization Pathway

2013

We have previously shown that soluble collagen and a human pathogen, echovirus 1 (EV1) cluster α2β1 integrin on the plasma membrane and cause their internalization into cytoplasmic endosomes. Here we show that cholesterol plays a major role not only in the uptake of α2β1 integrin and its ligands but also in the formation of α2 integrin-specific multivesicular bodies (α2-MVBs) and virus infection. EV1 infection and α2β1 integrin internalization were totally halted by low amounts of the cholesterol-aggregating drugs filipin or nystatin. Inhibition of cholesterol synthesis and accumulation of lanosterol after ketoconazole treatment inhibited uptake of collagen, virus and clustered integrin, an…

IntegrinsNystatinFluorescent Antibody TechniqueBiochemistryCollagen receptorchemistry.chemical_compoundBINDINGMolecular Cell BiologyInternalizationLipid raftREQUIRESmedia_common0303 health sciencesMicroscopy ConfocalMultidisciplinarybiologyQRIMMUNODEFICIENCY-VIRUS TYPE-1RNA REPLICATIONCellular StructuresExtracellular MatrixEnterovirus B Human3. Good healthCell biologyProtein TransportCholesterolENTRYCytochemistryMedicineMembranes and Sortinglipids (amino acids peptides and proteins)CollagenIntegrin alpha2beta1Research ArticleSignal TransductionViral EntryEndosomeSciencemedia_common.quotation_subjecteducationIntegrinLOW-DENSITY-LIPOPROTEINMicrobiologyFilipinClathrinGPI-ANCHORED PROTEINS03 medical and health sciencesVirologyCell Line TumorCell AdhesionHumansFilipinBiology030304 developmental biology030306 microbiologyCell MembraneVirus Uncoatingta1182TRANSPORTLIPID RAFTSMicroscopy ElectronSubcellular Organelleschemistrybiology.protein3111 BiomedicineChromatography Thin LayerCELL-MEMBRANESViral Transmission and InfectionPLoS ONE
researchProduct

Cytokine production pathway in the elderly.

1996

It is well known that aging is associated with various alterations in lymphoid cell functions, particularly with a progressive decline in immune responsiveness to exogenous antigens and increasing incidence of autoimmune phenomena. Many studies have been focused on the mechanisms of the immunologic features of aging. this review describes our results of studies performed to determine the influence of age on the capacity to produce interleukin-2 (IL-2), interferon-gamma (IFN-gamma), interleukin-4 (IL-4), interleukin-t (IL-5), interleukin-6 (IL-6) and tumor necrosis factor (TNF). Mitogen-stimulated cultures of mononuclear cells (MNC) from human beings were assessed for cytokine-producing capa…

Interleukin 2Agingmedicine.medical_treatmentT cellT-LymphocytesImmunologyBiologyIn Vitro TechniquesLymphocyte ActivationInterferon-gammaMiceImmune systemAntigenmedicineAnimalsHumansInterferon gammaLymphotoxin-alphaImmunodeficiencyAgedmedicine.diseaseCytokinemedicine.anatomical_structureImmunologyCytokinesInterleukin-2Tumor necrosis factor alphamedicine.drugImmunologic research
researchProduct

Interleukin 2 treatment in HIV-1 infection

2006

Interleukin 2Text miningbusiness.industryImmunologymedicineHuman immunodeficiency virus (HIV)InterleukinGeneral Medicinebusinessmedicine.disease_causemedicine.drugThe Lancet
researchProduct

Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?

2017

<b><i>Background:</i></b> Regulation of body iron occurs at cellular, tissue, and systemic levels. In healthy individuals, iron absorption and losses are minimal, creating a virtually closed system. In the setting of chronic kidney disease and hemodialysis (HD), increased iron losses, reduced iron absorption, and limited iron availability lead to iron deficiency. Intravenous (IV) iron therapy is frequently prescribed to replace lost iron, but determining an individual’s iron balance and stores can be challenging and imprecise, contributing to uncertainty about the long-term safety of IV iron therapy. <b><i>Summary:</i></b> Patients on HD recei…

Iron030232 urology & nephrologyPhysiology030204 cardiovascular system & hematologyDirect reduced iron03 medical and health sciences0302 clinical medicineHepcidinmedicineHomeostasisHumansErythropoiesisRenal Insufficiency ChronicHemochromatosischemistry.chemical_classificationbiologybusiness.industryIron deficiencymedicine.diseaseTrace ElementschemistryNephrologyTransferrinToxicitybiology.proteinErythropoiesisAdministration IntravenousbusinessKidney diseaseAmerican journal of nephrology
researchProduct

A genome-wide transcriptional study reveals that iron deficiency inhibits the yeast TORC1 pathway

2019

Iron is an essential micronutrient that participates as a cofactor in a broad range of metabolic processes including mitochondrial respiration, DNA replication, protein translation and lipid biosynthesis. Adaptation to iron deficiency requires the global reorganization of cellular metabolism directed to optimize iron utilization. The budding yeast Saccharomyces cerevisiae has been widely used to characterize the responses of eukaryotic microorganisms to iron depletion. In this report, we used a genomic approach to investigate the contribution of transcription rates to the modulation of mRNA levels during adaptation of yeast cells to iron starvation. We reveal that a decrease in the activity…

IronSaccharomyces cerevisiaeBiophysicsRibosome biogenesisSaccharomyces cerevisiaeMechanistic Target of Rapamycin Complex 1Biochemistry03 medical and health sciencesStructural BiologyRibosomal proteinTranscription (biology)Gene Expression Regulation FungalLipid biosynthesisGeneticsHumansRNA MessengerPhosphorylationMolecular BiologyGene030304 developmental biology0303 health sciencesAnemia Iron-Deficiencybiology030306 microbiologyChemistryIron deficiencyRNA polymerasesRNATORbiology.organism_classificationAdaptation PhysiologicalYeastCell biologyDNA-Binding ProteinsGene Expression RegulationProtein BiosynthesisSignal transductionTranscription
researchProduct